Panel de control de cohortes
La misión del GP2 es comprender la arquitectura genética de la enfermedad de Parkinson (EP) mediante el genotipado de grupos de pacientes diversos y el estudio de formas de la EP de las cuales se sospecha que son monogénicas. Para apoyar esta misión, seguimos recopilando cohortes diversas de todo el mundo a través de la colaboración y compartiendo datos, procesos y resultados de manera abierta. Explore el siguiente panel de control, donde encontrará los logros alcanzados hasta la fecha, y vuelva a visitar esta página periódicamente, ya que actualizamos los datos trimestralmente.
Datos globales totales
Última actualización: 9 de septiembre del 2021 | Diseño original del equipo GP2 Hackathon 2021: Mary Makarious, Kajsa Brolin, Yeajin Song y Anastasia Illarionova
UMUDALL
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
Ancestry Breakdown for Samples Completed
ShowScroll right for more
Ancestry | PD Cases | Healthy Controls | Parkinson's Adjacent Disorders | Prodomal | Total Non-PD Samples |
---|---|---|---|---|---|
aac - african admixed | 1 | 0 | 0 | Pending | 0 |
afr - african ancestry | 1 | 0 | 0 | Pending | 0 |
fin - finnish population isolate | 0 | 0 | 0 | Pending | 0 |
aj - ashkenazi jewish | 3 | 0 | 0 | Pending | 0 |
amr - latino and indigenous people of the americas | 0 | 0 | 0 | Pending | 0 |
eur - general european ancestry | 85 | 3 | 0 | Pending | 3 |
eas - east asian ancestry | 0 | 0 | 0 | Pending | 0 |
sas - south asian ancestry | 0 | 0 | 0 | Pending | 0 |
cas - central asian ancestry | 1 | 0 | 0 | Pending | 0 |
mde - middle eastern ancestry | 0 | 0 | 0 | Pending | 0 |
cah - complex admixture history | 0 | 0 | 0 | Pending | 0 |
total | 91 | 3 | 0 | 0 | 3 |
Total for all completed samples | 94 |
UPENN U19 Cohort
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
Ancestry Breakdown for Samples Completed
ShowScroll right for more
Ancestry | PD Cases | Healthy Controls | Parkinson's Adjacent Disorders | Prodomal | Total Non-PD Samples |
---|---|---|---|---|---|
aac - african admixed | 9 | 0 | 0 | Pending | 0 |
afr - african ancestry | 10 | 0 | 0 | Pending | 0 |
fin - finnish population isolate | 1 | 0 | 0 | Pending | 0 |
aj - ashkenazi jewish | 45 | 0 | 7 | Pending | 7 |
amr - latino and indigenous people of the americas | 4 | 0 | 0 | Pending | 0 |
eur - general european ancestry | 203 | 1 | 10 | Pending | 11 |
eas - east asian ancestry | 3 | 0 | 0 | Pending | 0 |
sas - south asian ancestry | 3 | 0 | 0 | Pending | 0 |
cas - central asian ancestry | 1 | 0 | 0 | Pending | 0 |
mde - middle eastern ancestry | 1 | 0 | 0 | Pending | 0 |
cah - complex admixture history | 1 | 0 | 0 | Pending | 0 |
total | 281 | 1 | 17 | 0 | 18 |
Total for all completed samples | 299 |
Van Andel Institute Brain Bank
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
VET-PD
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
VIPD
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
Ancestry Breakdown for Samples Completed
ShowScroll right for more
Ancestry | PD Cases | Healthy Controls | Parkinson's Adjacent Disorders | Prodomal | Total Non-PD Samples |
---|---|---|---|---|---|
aac - african admixed | 2 | 0 | 0 | Pending | 0 |
afr - african ancestry | 1 | 0 | 0 | Pending | 0 |
fin - finnish population isolate | 0 | 0 | 0 | Pending | 0 |
aj - ashkenazi jewish | 23 | 7 | 0 | Pending | 7 |
amr - latino and indigenous people of the americas | 0 | 0 | 0 | Pending | 0 |
eur - general european ancestry | 515 | 105 | 1 | Pending | 106 |
eas - east asian ancestry | 2 | 4 | 0 | Pending | 4 |
sas - south asian ancestry | 11 | 2 | 0 | Pending | 2 |
cas - central asian ancestry | 0 | 0 | 0 | Pending | 0 |
mde - middle eastern ancestry | 3 | 0 | 0 | Pending | 0 |
cah - complex admixture history | 3 | 1 | 0 | Pending | 1 |
total | 560 | 119 | 1 | 0 | 120 |
Total for all completed samples | 680 |
WEHI - Integrating molecular and omics approaches in Parkinson’s disease
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
Yale Medical School
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
Ancestry Breakdown for Samples Completed
ShowScroll right for more
Ancestry | PD Cases | Healthy Controls | Parkinson's Adjacent Disorders | Prodomal | Total Non-PD Samples |
---|---|---|---|---|---|
aac - african admixed | 0 | 1 | 0 | Pending | 1 |
afr - african ancestry | 0 | 1 | 0 | Pending | 1 |
fin - finnish population isolate | 0 | 0 | 0 | Pending | 0 |
aj - ashkenazi jewish | 2 | 1 | 0 | Pending | 1 |
amr - latino and indigenous people of the americas | 1 | 0 | 0 | Pending | 0 |
eur - general european ancestry | 14 | 5 | 21 | Pending | 26 |
eas - east asian ancestry | 0 | 0 | 0 | Pending | 0 |
sas - south asian ancestry | 0 | 0 | 0 | Pending | 0 |
cas - central asian ancestry | 0 | 0 | 0 | Pending | 0 |
mde - middle eastern ancestry | 1 | 0 | 0 | Pending | 0 |
cah - complex admixture history | 0 | 0 | 1 | Pending | 1 |
total | 18 | 8 | 22 | 0 | 30 |
Total for all completed samples | 48 |
YOPDFL (Young Onset Parkinson's Disease)
Number of Samples Completed and Expected
Case Samples
Case Samples
Non-PD Samples
Non-PD Samples
Total Samples
Total Samples
Solicitar conjunto de datos de AMP-PD
Una vez que el GP2 completa el genotipado de una cohorte, todos los datos se comparten en la plataforma segura AMP® PD. Regístrese para solicitar acceso a estos datos.
Aportar una cohorte
Si desea colaborar con el GP2, póngase en contacto con nosotros para aportar una cohorte o infórmese sobre cómo hacerse miembro.
Conozca los miembros del GP2 de todo el mundo
Explore las organizaciones miembro que hacen que nuestra investigación sea posible gracias a su colaboración y contribución de muestras y datos.